15 March 2024, Observe Medical ASA (the "Company"): Soleglad Invest AS (a
closely related party to Kathrine Gamborg Andreassen, director of the board of
directors in the Company), has on 15 March 2024 sold 200,000 shares in the
Company at a price of NOK 0.42.

Following the sale, Soleglad Invest AS holds 618,760 shares in the Company. Copy
of notification is attached hereto.